Press Release: Director's Dealings announcement according to --15a WpHG (the German Securities Trading Act)

Biofrontera AG / Director's Dealings announcement according to --15a WpHG (the German Securities Trading Act) . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.

Details of the person subject to the disclosure requirement Name: Baumann, Jürgen Person with executive functions: Member of administrative Professional role: or supervisory body

Designation of the financial instrument ISIN: DE0006046113 Designation: Shares of Biofrontera AG

Additional details on derivatives ISIN underlying instrument: DE000A1KQ9Q Designation: 5% option bond Strike price: 100.00 Price multiplier: 1 Expiration date: 31.12.2016

Details of the transaction Type of transaction: Sale Date: 25.06.2015 Place (stock exchange): Düsseldorf Price: 86.70 Currency: EUR Business volume: 3,700

Details of the company with the publishing obligation: Issuer: Biofrontera AG Hemmelrather Weg 201 51377 Leverkusen Germany

ISIN: DE0006046113 WKN: 604611

This announcement is distributed by Nasdaq OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Biofrontera AG via Globenewswire

HUG#1932560

--- End of Message ---

Biofrontera AG

Hemmelrather Weg 201 Leverkusen Germany

WKN: 604611;ISIN: DE0006046113;

Listed: Freiverkehr in Börse Stuttgart,

Freiverkehr in Börse Berlin,

Freiverkehr in Bayerische Börse München,

Regulierter Markt in Frankfurter Wertpapierbörse,

Regulierter Markt in Börse Düsseldorf;

http://www.biofrontera.com/ (END) Dow Jones Newswires

   June 29, 2015 10:15 ET (14:15 GMT)- - 10 15 AM EDT 06-29-15